{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T19:55:47Z","timestamp":1773604547260,"version":"3.50.1"},"reference-count":54,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T00:00:00Z","timestamp":1219795200000},"content-version":"vor","delay-in-days":3070,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:p>Proinflammatory cytokines such as interleukin 6 (IL\u20106), tumour necrosis factor \u03b1 (TNF\u2010\u03b1) and IL\u20101\u03b2 are considered to be involved in the pathogenesis of multiple myeloma (MM). In the present study, we examined a G\/C polymorphism at position \u2212174 in the promoter region of IL\u20106, a biallelic polymorphism at position \u2212308 in the promoter region of TNF\u2010\u03b1, the <jats:italic>Taq<\/jats:italic>I restriction fragment length polymorphism in exon 5 of IL\u20101\u03b2 and a variable number of identical tandem repeat polymorphisms in intron 2 of IL\u20101 receptor antagonist (IL\u20101Ra) genes. The alleles of these loci are known to influence the level of production of the cytokines and the IL\u20101Ra. Seventy\u2010three patients with MM, 27 with monoclonal gammopathy of undetermined significance (MGUS) and 129 healthy individuals were included. No difference was found between patients and healthy controls or between MM and MGUS patients in the distributions of genotypes and frequencies of alleles of the IL\u20106 (\u2212174), TNF\u2010\u03b1 (\u2212308), IL\u20101\u03b2<jats:italic>Taq<\/jats:italic>I and IL\u20101Ra gene polymorphisms. No associations between the polymorphisms at the loci under study and clinical factors such as age, sex, clinical stage at onset and M\u2010protein type were observed. Our results indicate that the cytokine (IL\u20106, TNF\u2010\u03b1 and IL\u20101\u03b2) and IL\u2010Ra gene polymorphisms do not confer susceptibility to the development of MM.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01963.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:23:09Z","timestamp":1047363789000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Interleukin 6, tumour necrosis factor \u03b1, interleukin 1\u03b2 and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma"],"prefix":"10.1111","volume":"109","author":[{"given":"ChengYun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DeRen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bergenbrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Sundblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"\u00d6sterborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,27]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"14","article-title":"Role of cytokines in multiple myeloma","volume":"36","author":"Anderson K.C.","year":"1999","journal-title":"Seminars in Haematology"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.9.2326.2326"},{"key":"e_1_2_6_4_2","first-page":"7172","article-title":"Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma","volume":"49","author":"Barlogie B.","year":"1989","journal-title":"Cancer Research"},{"issue":"1","key":"e_1_2_6_5_2","first-page":"23","article-title":"New insight in the clinical biology of multiple myeloma","volume":"34","author":"Bataille R.","year":"1997","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/319516a0"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb03793.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1996.d01-65.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(90)90273-T"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2385::AID-CNCR13>3.0.CO;2-A"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb06330.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood.V89.1.227","article-title":"Interleukin\u20106 inhibits induced apoptosis and stress\u2010activated protein kinase activation in multiple myeloma cells","volume":"89","author":"Chauhan D.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.4049\/jimmunol.137.12.3748","article-title":"Stimulation of B cell growth and differentiation by murine recombinant interleukin 1","volume":"137","author":"Chiplunkar S.","year":"1986","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01101.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb05549.x"},{"key":"e_1_2_6_16_2","first-page":"239","article-title":"Polymorphism within the second intron of the IL\u20101 receptor antagonist gene in patients with hematopoietic malignancies","volume":"2","author":"Demeter J.","year":"1996","journal-title":"Cytokines and Molecular Therapy"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400873"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U"},{"key":"e_1_2_6_20_2","first-page":"52","article-title":"Cytokine (IL\u20106, TNF\u2010alpha, IL\u20101 alpha) and soluble interleukin\u20102 receptor as serum tumor markers in multiple myeloma","volume":"20","author":"Filella X.","year":"1996","journal-title":"Cancer Detection and Prevention"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2629"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/306378a0"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01415.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1998.00277.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.3"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.3063.3063"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.11008"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(88)90011-6"},{"key":"e_1_2_6_30_2","first-page":"65","article-title":"Tumor necrosis factor is a survival and proliferation factor for human myeloma cells","volume":"10","author":"Jourdan M.","year":"1999","journal-title":"European Journal of Cytokine Networks"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409049687"},{"key":"e_1_2_6_32_2","first-page":"4","article-title":"Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma","volume":"32","author":"Klein B.","year":"1995","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60015-9"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1491.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1182\/blood.V93.1.300","article-title":"Comparison of interleukin\u20101\u03b2 expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"93","author":"Lacy M.Q.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1995.1076"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00662.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61351-2"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90696-3"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860715)58:2<394::AID-CNCR2820580234>3.0.CO;2-8"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1977.tb16773.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1076"},{"key":"e_1_2_6_43_2","first-page":"267","article-title":"A novel NlaIII polymorphism in the human IL\u20106 promoter","volume":"25","author":"Olomolaiye O.","year":"1998","journal-title":"European Journal of Immunogenetics"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1981.tb00486.x"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1992.tb01480.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.4049\/jimmunol.146.10.3462","article-title":"IL\u20106 and tumor necrosis factor\u2010alpha. Autocrine and paracrine cytokines involved in B cell function","volume":"46","author":"Rieckmann P.","year":"1991","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_47_2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.142.2.549","article-title":"IL\u20101 stimulates IL\u20106 production in endothelial cells","volume":"142","author":"Sironi M.","year":"1989","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00217368"},{"key":"e_1_2_6_49_2","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.157.9.3949","article-title":"Intracellular IL\u20101beta is an inhibitor of Fas\u2010mediated apoptosis","volume":"157","author":"Tatsuta T.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_50_2","first-page":"868","article-title":"Modulation of osteoclast\u2010activating factor activity of multiple myeloma bone marrow cells by different interleukin\u20101 inhibitors","volume":"24","author":"Torcia M.","year":"1996","journal-title":"Experimental Hematology"},{"key":"e_1_2_6_51_2","first-page":"28","article-title":"Familial myeloma","volume":"84","author":"Tzilianos M.","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.10.3574"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01350.x"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/1.5.353"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.3195"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01963.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01963.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01963.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T07:08:29Z","timestamp":1695884909000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01963.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01963.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01963.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]},"assertion":[{"value":"2008-08-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}